Latest / Becker’s Healthcare Podcast / The Future of Oncology Strategy, AI and CMS Reform with Jordan Johnson
Transcript
- 0:02- Every health system executive right now is being
- 0:04- asked to do something that has no useful
- 0:06- precedent,
- 0:07- make durable technology decisions in an environment that
- 0:10- looks meaningfully different every six months.
- 0:13- The pace isn't slowing,
- 0:14- the vendor landscape isn't getting simpler, and the
- 0:17- cost of missteps keeps rising.
- 0:19- Becker's eleventh annual IT and Revenue Cycle Conference,
- 0:23- The Future of AI and Digital Health, exists
- 0:25- for exactly this challenge.
- 0:27- Here, you'll find more than 2,500 executive level
- 0:30- attendees,
- 0:31- 600 plus speakers, and four days of sessions
- 0:34- built around the questions leaders are actually wrestling
- 0:36- with.
- 0:37- How to scale AI responsibly,
- 0:39- how to protect increasingly complex systems,
- 0:42- how to wring more performance out of the
- 0:44- revenue cycle, and how to make tech investments
- 0:46- that hold up over time.
- 0:48- Join us September fourteenth through the seventeenth at
- 0:51- the Hilton Chicago.
- 0:53- You can register on our events page at
- 0:55- beckershospitalreview.com
- 0:57- by clicking on the events tab in the
- 0:59- upper right.
- 1:01- This is Scott Becker with the Beckers Health
- 1:03- Care Podcast.
- 1:04- We're thrilled to be joined by a a
- 1:06- brilliant leader. We're joined today by Jordan Johnson
- 1:09- of Bridge Oncology.
- 1:11- Jordan's gonna talk to us about trends he's
- 1:13- watching. I would see that oncology space is
- 1:15- so challenging right now and a lot more.
- 1:17- Jordan,
- 1:18- take a moment and tell us a bit
- 1:20- about yourself and and what you do.
- 1:22- Oh, you bet. Scott, pleasure to be here,
- 1:24- and talk about some of this with all
- 1:26- the chaos that we have going on. But
- 1:28- my name is Jordan Johnson, and I'm the
- 1:30- cofounder of Bridge Oncology
- 1:32- along with doctor Arpit Chhabra, but started my
- 1:34- career clinically
- 1:35- almost twenty I guess it's been twenty one
- 1:37- years ago, as a radiologic technologist doing HRACT
- 1:40- and then as a radiation therapist.
- 1:42- Then moved on into the executive leadership roles
- 1:45- for the oncology service line, revenue cycle, compliance,
- 1:49- and now health care law. But today, our
- 1:51- team really works with a broad spectrum. We
- 1:53- work with hospitals, health systems.
- 1:56- We work with large health care attorney firms.
- 1:58- We work with
- 2:00- advisors, and some of the big advisors that
- 2:02- most people know by name,
- 2:04- on the clinical, operational, and financial performance
- 2:07- of healthcare in general, but with a specific
- 2:10- focus
- 2:11- in oncology.
- 2:13- And our focus really at Bridge has been
- 2:15- quite unique because we've combined all of this
- 2:18- together
- 2:19- to where we didn't wanna be just another
- 2:21- healthcare consulting company that writes reports, gives you
- 2:24- a how to manual, and then moves on.
- 2:26- But we actually are able to build things
- 2:28- and then execute,
- 2:30- execute. So that really, really points
- 2:33- out the expertise of our staff. I mean,
- 2:35- we onboard and have physicians. We have data
- 2:38- analysts. We have forensic accountants, health care attorneys,
- 2:41- pharmacists, infusion leaders, admins.
- 2:43- And so you put all that together, and
- 2:45- you really can do something
- 2:47- pretty unique.
- 2:48- But our mission has been
- 2:50- pretty narrowly focused, meaning,
- 2:52- we wanna protect, the current access to to
- 2:55- high quality cancer care and make sure that
- 2:57- it's there close to home for patients.
- 3:00- And this has really come under fire under
- 3:01- the past few years as the administration
- 3:03- looks to to change things up, but we
- 3:06- wanna redefine
- 3:07- a completely failed model. We know the current
- 3:09- model,
- 3:10- RFK has talked about this, Oz has talked
- 3:12- about this.
- 3:14- We know that the current model is broken,
- 3:15- that it's failed,
- 3:17- and we can't just put Band Aids on
- 3:18- anymore, but we have to redefine it. And
- 3:20- so,
- 3:21- we still believe that, you know, we have
- 3:23- to preserve,
- 3:24- some of the fundamentals,
- 3:27- operationally,
- 3:28- financially
- 3:29- to ensure that things continue to move forward
- 3:31- and survive. So,
- 3:33- that's a little bit about me, and I
- 3:35- hope that helps a little bit.
- 3:37- No. Thank you so much. And and talk
- 3:39- a little bit about you you talked about
- 3:41- doctor Oz's perspective,
- 3:44- What trends are you watching in oncology currently?
- 3:47- And what trends are you watching in health
- 3:48- care currently?
- 3:49- Absolutely. I mean, we're coming off the last
- 3:51- two weeks where we or really three weeks
- 3:53- where we saw, you know, the CMS proposed
- 3:55- rules,
- 3:56- both eighteen fifty on the OPPS,
- 3:59- hospital side, and then, of course, last week,
- 4:01- eighteen forty eight on the MPFS side. And
- 4:04- I think a lot of people were
- 4:05- I I won't say we were shocked. We
- 4:07- knew all this was coming. The writing's been
- 4:09- on the wall for a while, but I
- 4:10- think,
- 4:11- it's really the biggest transformation in health care
- 4:13- in decades. And I think that's what we're
- 4:15- looking at is most people tend to look
- 4:17- at CMS proposals and say simply, you know,
- 4:20- what are my rates gonna look like next
- 4:21- year? How much am I getting cut? How
- 4:23- much am I getting paid? And I think
- 4:24- that's been the wrong question. I think the
- 4:26- better question is, what is CMS signaling? What
- 4:29- are they trying to tell us? And so,
- 4:31- what we're really watching and looking forward forward
- 4:33- thinking about is, you know, when I look
- 4:35- at the 2027 proposal, we see several major
- 4:38- signals.
- 4:39- I think we're seeing, a signal on the
- 4:41- move towards the total cost of care rather
- 4:44- than a volume based reimbursement, which we've said
- 4:47- for decades for fee for service.
- 4:49- I think they made it very clear that
- 4:50- AI is becoming now a reimbursable clinical tool,
- 4:53- but only if it's governed, measurable, and creates
- 4:56- actually documented value.
- 4:58- I think we're also seeing increased attention to,
- 5:01- program integrity, documentation, and operational accountability.
- 5:05- And then the biggest thing, I think, that
- 5:07- everybody sees is it's CMS continuing to march
- 5:11- towards,
- 5:12- site neutrality.
- 5:13- The proposal to expand,
- 5:15- physician fee for service, you know, equivalent payments
- 5:17- for certain imaging service performed
- 5:20- and accepted off campus hospital outpatient departments
- 5:24- isn't just about imaging reimbursement. It's really another
- 5:26- indication that CMS is becoming less willing to
- 5:29- pay different rates simply because care is delivered
- 5:32- in a hospital only setting. And I think
- 5:35- that philosophy has implications,
- 5:37- you know, well beyond imaging,
- 5:39- and will continue to reshape the outpatient strategy.
- 5:42- And then, you know, the hot topic, I
- 5:44- think, for the and everybody is the three
- 5:47- forty b reform. I mean,
- 5:49- again, been talked about for years. So this
- 5:51- reimbursement change of three forty b really sent
- 5:54- a pretty powerful message for years. You know,
- 5:56- the health systems have relied on the pharmacy
- 5:58- margin
- 5:59- to subsidize other other service lines, you know,
- 6:02- behavioral health, wound care,
- 6:04- and even recently some oncology services. And so
- 6:07- I think CMS now says, hey.
- 6:09- You know, we're looking and signaling that, those
- 6:12- cross subsidization models
- 6:14- may not be sustainable indefinitely. I think organizations,
- 6:18- you know, are gonna need to understand what
- 6:20- the true economics are,
- 6:22- for each each service line rather than relying
- 6:25- on these historical
- 6:27- reimbursement advantages.
- 6:29- And so you mentioned oncology specifically.
- 6:32- All of those, I think, we're gonna see
- 6:34- significant
- 6:35- migration
- 6:36- of certain services, infusion, theranostics,
- 6:39- imaging, radiation oncology.
- 6:41- They're all gonna continue to evolve as reimbursement
- 6:43- changes,
- 6:45- alter where the where the care can be
- 6:47- delivered
- 6:48- most efficiently and effectively.
- 6:51- And I think those that optimize the operational
- 6:54- cost, the governance,
- 6:55- and patient access will be positioned far better,
- 6:58- than those relying on the current, you know,
- 7:00- the legacy reimbursement structures.
- 7:03- Thank you. And do you wanna take a
- 7:04- moment on what you're most focused on and
- 7:06- excited about currently?
- 7:08- When it's through the end of the year
- 7:09- through next year, what are you most focused
- 7:11- on and excited about?
- 7:12- I'm excited about it all,
- 7:14- right now. Thank you. I'm proud that we've,
- 7:16- you know, grown from from being,
- 7:19- primarily in the in the infancy stages of
- 7:21- a company,
- 7:23- as a really a radiation oncology company to
- 7:25- more of,
- 7:26- oncology strategy, health policy
- 7:29- in that, legal health execution firm.
- 7:32- We've expanded those,
- 7:34- into infusion operations. I'm excited about that.
- 7:37- Our pharmacy strategy, Theranostics,
- 7:39- AI governance,
- 7:41- you know, it's not enough just to react
- 7:43- to these reimbursement changes. We wanna help people
- 7:45- understand where policy's heading,
- 7:48- before those changes actually arise.
- 7:50- And I think, you know, over the last
- 7:52- year,
- 7:53- we've helped
- 7:55- organizations, obviously, recover significant revenue,
- 7:58- improve a lot of their operations, strengthen their
- 8:00- compliance programs, and prepare for some of these
- 8:02- changes.
- 8:03- I mean, for example, you know, radiation oncology
- 8:06- underwent the largest CPT code change that is
- 8:09- still a nightmare today that went into effect
- 8:11- January 1. And,
- 8:13- you know, quite frankly, we weren't prepared for
- 8:15- it.
- 8:16- Policy wasn't prepared for it. Governing societies and
- 8:19- bodies
- 8:20- definitely,
- 8:21- were not prepared for it and didn't prepare
- 8:23- a lot of the payers, so we're still
- 8:25- seeing fallout from that. So it's making sure
- 8:27- that we're way ahead of the game. And
- 8:29- to do that, you gotta enlist others. You've
- 8:32- got to line side by side. You can
- 8:34- no longer be, you know, the person or
- 8:36- the company that says, hey.
- 8:38- Just a few of us can do it
- 8:39- all. So I'm excited about the work that
- 8:41- we've lined alongside.
- 8:43- I mentioned Sanjay and Doug, Sanjay Joneja, Doug
- 8:47- Flora,
- 8:47- with the Tensor Black team, which is, you
- 8:50- know, we're just exploring how does
- 8:52- AI how can we move beyond just another
- 8:54- point solution
- 8:56- and become really a trusted infrastructure that actually
- 8:58- helps providers,
- 9:00- make better operational, financial, and clinical decisions.
- 9:03- And I think the opportunity isn't just building
- 9:05- AI. It's building AI that aligns with all
- 9:08- of these policies and governance,
- 9:10- and that's where I believe things are, you
- 9:12- know, positioned to better succeed.
- 9:15- And I think,
- 9:16- to kind of add to that, I think
- 9:18- what excites me most is I don't think
- 9:20- we've even reached the beginning of what's possible
- 9:22- and where this stuff is going. I think
- 9:24- there's a lot of exposure right now. Meaning,
- 9:26- I think there's a lot of people that
- 9:27- have, you know, we we all heard the
- 9:29- term fake it till you make it. And,
- 9:31- unfortunately, in this landscape, now that the screws
- 9:33- have tightened,
- 9:34- there is no fake it till you make
- 9:35- it. So I think health care is entering
- 9:37- a period where reimbursement technology, policy, operations
- 9:41- are converging much faster than ever before. So
- 9:44- organizations that understand those intersections
- 9:47- will lead to the next decade of where
- 9:49- CMS is positioned as for transformation. And so
- 9:52- I think that's why you really have to
- 9:54- have the people that understand this. And the
- 9:55- people that understand it best are the people
- 9:57- that can move fast and align with others
- 9:59- in the space that understand this too.
- 10:02- Jordan, what a pleasure to visit with you.
- 10:04- One more question.
- 10:06- Single piece of advice for entrepreneurs, for founders,
- 10:09- what advice would you give? Oh my gosh.
- 10:12- That's that's a great question. I wish I
- 10:14- I wish I had this, twenty one years
- 10:16- ago, and somebody had told me this. Of
- 10:17- course, I don't know if they could've, foreseen
- 10:19- everything that was gonna change and happen in
- 10:21- health care. But what advice would I give
- 10:24- either a start up or evolving leaders? And
- 10:27- I would tell leaders to become students of
- 10:29- the system,
- 10:30- not just a specialist in a department or
- 10:33- a focus.
- 10:34- Health care has become way too interconnected
- 10:37- for finance to operate independently from clinicians
- 10:40- or compliance to operate independently from technology.
- 10:43- So I think the leaders who are actually
- 10:45- gonna thrive over the next decade will understand
- 10:48- how all of those pieces fit together, and
- 10:50- I would encourage those leaders
- 10:51- to spend more time asking why than asking
- 10:54- what. I think it's easy to measure the
- 10:56- metrics. It's much harder to understand
- 10:59- the system that's actually producing those metrics.
- 11:02- So that's probably what I would leave them
- 11:04- with.
- 11:05- Love that. I absolutely love it. Jordan Johnson,
- 11:07- what a pleasure to visit with you today
- 11:09- on the Becker's Healthcare podcast.
- 11:11- Thank you for taking the time with us.
- 11:12- Thank you very, very much. You bet.